It is still not known whether hematopoiesis reconstituted by autografting with the peripheral blood hematopoietic progenitors (CPCs) after myeloablative high dose radiotherapy and/or chemotherapy is durable and capable of coping with the increased demand imposed by boost radiotherapy, surgery, or infection.
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors / S. Siena, M. Bregni, M. Di Nicola, F. Ravagani, F. Peccatori, L. Gandola, F. Lombardi, C. Tarella, G. Bonadonna, A. M. Gianni. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 5:10(1994 Dec), pp. 935-41-941.
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors
S. Siena;C. Tarella;A. M. Gianni
1994
Abstract
It is still not known whether hematopoiesis reconstituted by autografting with the peripheral blood hematopoietic progenitors (CPCs) after myeloablative high dose radiotherapy and/or chemotherapy is durable and capable of coping with the increased demand imposed by boost radiotherapy, surgery, or infection.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
